Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis
- 1 June 1991
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 62 (6) , 737-743
- https://doi.org/10.1016/0049-3848(91)90377-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- MODERATE DOSES OF ASPIRIN AND RISK OF BLEEDING IN RENAL FAILUREThe Lancet, 1986
- Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.Journal of Clinical Investigation, 1985
- Double‐Blind Randomized Trial of the Effect of Ticlopidine in Arteriovenous Fistulas for HemodialysisArtificial Organs, 1985
- Thromboprophylactic Effect of Ticlopidine in Arteriovenous Fistulas for HaemodialysisScandinavian Journal of Urology and Nephrology, 1985
- Antithrombin-III and Platelets in Haemodialysis PatientsNephron, 1981
- Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patients.Journal of Clinical Pathology, 1980
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957
- A STUDY OF THE COAGULATION DEFECT IN HEMOPHILIA AND IN JAUNDICE.*The Lancet Healthy Longevity, 1935